poisar

Stocks · News reference

Moderna shares are trading higher after the company and Merck announced topline results from the Phase 3 INTerpath-001 trial met its primary and a key secondary endpoint.

BenzingaAug 19, 2026, 12:29 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 19, 2026, 12:29 PM
Checked
Aug 19, 2026, 12:29 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading